|   LifeSciVC

A Hat Trick Of Cell And Gene Therapy IPOs: Avro, Magenta, and Unum

By Bruce Booth, DPhil, Partner

Last week, AvroBio and Magenta Therapeutics priced their IPOs on the same night. Less than three months earlier, Unum Therapeutics priced its IPO. All three biotech companies are emerging leaders in the cell and gene therapy space, broadly defined. They are now well financed for the next chapter in their respective journeys to bring new potentially transformative therapies to cancer, rare disease, and autoimmune patients.

Read more.